GEN Exclusives

More »

GEN News Highlights

More »
Jan 5, 2011

Thomson Reuters and ChemAxon Couple Offerings to Search and Visualize Chemical Patents

  • The IP solutions business of Thomson Reuters agreed to provide its chemical IP data feeds called Markush structures and patent data to users of ChemAxon’s JChem chemical software platform. The deal couples a search and analysis solution with a bioinformatic platform.

    The Markush structures are part of Thomson Reuters’ Derwent World Patents Index® (DWPI) database. The Markush database contains data on the relationship or families of 550,000 patents plus 1.7 million related, exemplified, specific compounds. It includes patents for pharmaceuticals, agrochemicals, and general chemistry spanning 26 patent-issuing authorities. Markush data is integrated with high-quality patent summary data from DWPI, enabling access to enhanced patent abstracts, family and assignee details, and relevant bibliographic data.

    ChemAxon’s JChem software allows life science professionals to structure and visualize chemical compounds for property prediction, virtual synthesis, screening, and drug design. “The ability to search and visualize complex chemical patents is critical to the work of life science R&D professionals,” notes Cindy Poulos, vp of product management, Thomson Reuters.

    “To date, however, this has been a challenge as there wasn’t a tool that enabled R&D end users to do this type of work themselves. Through this partnership, Thomson Reuters and ChemAxon are making a comprehensive worldwide database of chemical compounds widely accessible in a user-friendly, flexible format to end users.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »